Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis
Troia Medical Journal · 06.01.2026 · 7 (1) · 10-18
DOI: 10.55665/troiamedj.1830321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Troia Medical Journal, online erschienen am 06.01.2026. Verfasst von Adil Uğur Çetin und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: none.
Themen: Intensivpflege, Sepsis
Abstract (Originalsprache)
Objective
Sepsis remains a major global health problem with high morbidity and mortality rates, mostly in intensive care unit (ICU) settings. The Pan-Immune Inflammation Value (PIIV), a composite marker derived from neutrophil, monocyte, platelet, and lymphocyte counts, has recently emerged as a potential indicator of systemic inflammation. This study aimed to evaluate the prognostic performance of PIIV and platelet-derived indices, including mean platelet volume (MPV) in predicting 30-day mortality among ICU-admitted sepsis patients.
Methods
This retrospective study included 191 adult patients with sepsis admitted to the ICU of a tertiary care hospi-tal. Laboratory parameters, including PIIV, MPV, PLR, and lactate, along with various clinical and laboratory parame-ters were recorded within the first 24 hours of ICU admission. Logistic regression analysis (LRA) and receiver operat-ing characteristic curve (ROC) analysis were performed to determine predictors of 30-day mortality.
Results
Of the total cohort, 96 patients (50.3%) died within 30 days after ICU admission. PIIV, MPV, and lactate levels were found to be elevated in non-survivors (p=0.001, p=0.003, and p=0.001, respectively). In multivariate LRA, PIIV (OR: 1.235; 95% CI: 1.086–1.404; p=0.001), MPV (OR: 1.346; 95% CI: 1.111–1.630; p=0.002), lactate, and urea were independently associated with mortality. ROC analysis showed that PIIV had an AUROC of 0.643 at a cut-off value of ≥1.2, while MPV had an AUROC of 0.623 at a cut-off of ≥11.5 fL.
Conclusion
Integrating PIIV and MPV into the clinical assessment of sepsis patients may improve decision-making in the management of critically ill septic patients in intensive care units.
Förderung
- none
Zitieren
APA
Çetin, A. U., Çetin, E. Ü., Kurtkulağı, Ö., Daş, M., Şimşek, E., Kamış, F., Aydemir, F. D., & Beyazıt, Y. (2026). Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis. Troia Medical Journal, 7(1), 10-18. https://doi.org/10.55665/troiamedj.1830321
Vancouver
Çetin AU, Çetin EÜ, Kurtkulağı Ö, Daş M, Şimşek E, Kamış F, et al. Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis. Troia Medical Journal. 2026;7(1):10-18. doi:10.55665/troiamedj.1830321
BibTeX
@article{etin2026,
author = {Çetin, Adil Uğur and Çetin, Ece Ünal and Kurtkulağı, Özge and Daş, Murat and Şimşek, Esen and Kamış, Fatih and Aydemir, Ferhan Demirer and Beyazıt, Yavuz},
title = {Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis},
journal = {Troia Medical Journal},
year = {2026},
volume = {7},
number = {1},
pages = {10--18},
doi = {10.55665/troiamedj.1830321}
}
EUVIMED